Cargando…
Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy
Mesenchymal stem cells (MSCs) possess pleiotropic properties that include immunomodulation, inhibition of apoptosis, fibrosis and oxidative stress, secretion of trophic factors, and enhancement of angiogenesis. These properties provide a broad spectrum for their potential in a wide range of injuries...
Autores principales: | Paulini, Janaina, Higuti, Eliza, Bastos, Rosana M. C., Gomes, Samirah A., Rangel, Érika B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187468/ https://www.ncbi.nlm.nih.gov/pubmed/28058051 http://dx.doi.org/10.1155/2016/9521629 |
Ejemplares similares
-
Therapeutic Potential of Mesenchymal Stem Cells in a Pre-Clinical Model of Diabetic Kidney Disease and Obesity
por: Sávio-Silva, Christian, et al.
Publicado: (2021) -
Failure of intrathecal allogeneic mesenchymal stem cells to halt progressive demyelination in two boys with cerebral adrenoleukodystrophy
por: Gupta, Ashish, et al.
Publicado: (2020) -
A novel strategy employing the flavonoid fisetin to halt the progression of renal fibrosis in obstructive nephropathy
por: Kwon, Tae-Hwan
Publicado: (2023) -
Fostering mesenchymal stem cell therapy to halt cytokine storm in COVID-19
por: Jeyaraman, Madhan, et al.
Publicado: (2021) -
Progenitor/Stem Cell Delivery by Suprarenal Aorta Route in Acute
Kidney Injury
por: Rangel, Érika B., et al.
Publicado: (2019)